Since diabetes and its co-morbidities are associated with hyperactive inflammation, netrin-1 could be a promising therapeutic candidate that reduces hypoglycemia while also ameliorating inflammation for diabetic individuals. Here, NTN1 is linked to diabetes mellitus.